74
Participants
Start Date
February 1, 2021
Primary Completion Date
January 16, 2024
Study Completion Date
April 9, 2024
Tacrolimus
Starting dose based on CYP3A5 genotype
Singapore General Hospital, Singapore
Singapore General Hospital
OTHER